MELTIN MMI is a Japanese cyborg-technology company specializing in bio-signal processing and robotic mechanisms for neurorehabilitation and avatar robots. Founded in 2013 in Tokyo, the company raised $18M in Series B (2018) from Sumitomo Dainippon Pharma, SBI Investment, and Daiichi Life Insurance. MELTIN's MELTz device provides neurorehabilitation for hand paralysis patients using bio-signal-driven robotic assistance. The company won the Microsoft Innovation Award at Cybathlon 2016 for enabling fine finger movements in amputees. MELTIN's long-term vision is full cyborg technology including artificial bodies and brain-machine interfaces.